Valuation Arecor Therapeutics plc

Equities

Delayed London S.E. Other stock markets 08:15:00 13/09/2024 BST			5-day change	1st Jan Change
78.50 ^GBX	-1.88%		-3.68%	-56.99%

09-11	Arecor Therapeutics plc Presents Positive Data from Phase I Clinical Trial of Ultra-Concentrated, Ultra-Rapid Acting Insulins	CI
07-23	Arecor Therapeutics Completes Retail Offer	MT

Fiscal Period: December	2021	2022	2023	2024	2025	2026
Capitalization ¹	111.3	73.48	55.89	30.21	-	-
Change	-	-34%	-23.94%	-45.96%	-	-
Enterprise Value (EV) ¹	93.02	60.68	49.14	26.17	28.32	32
Change	-	-34.77%	-19.01%	-46.74%	8.21%	13%
P/E ratio	-14.8x	-7.5x	-6.52x	-	-	-
PBR	-	4.21x	5.87x	3.29x	13x	-14.4x
PEG	0.2x	-0.4x	0.5x	-	-	-
Capitalization / Revenue	96.1x	30.6x	12.2x	4.36x	2.75x	2.26x
EV / Revenue	80.3x	25.3x	10.7x	3.78x	2.57x	2.39x
EV / EBITDA	-14.8x	-5.9x	-5.66x	-3.89x	-6.56x	-10.8x
EV / EBIT	-14.4x	-5.71x	-5.36x	-3.33x	-5.28x	-7.98x
EV / FCF	-	-5.48x	-8.2x	-3.59x	-21.4x	-18.9x
FCF Yield	-	-18.3%	-12.2%	-27.8%	-4.68%	-5.3%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	-0.27	-0.32	-0.28	-	-	-
Distribution rate	-	-	-	-	-	-
Net sales ¹	1.158	2.403	4.573	6.931	11	13.39
EBITDA ¹	-6.268	-10.29	-8.679	-6.723	-4.314	-2.967
EBIT ¹	-6.439	-10.63	-9.175	-7.85	-5.36	-4.012
Net income	-6.169	-9.26	-8.554	-	-	-
Net Debt ¹	-18.32	-12.81	-6.752	-4.035	-1.886	1.795
Reference price ²	4.0000	2.4000	1.8250	0.8000	0.8000	0.8000
Nbr of stocks (in thousands)	27,835	30,618	30,627	37,757	-	-
Announcement Date	25/04/22	20/04/23	16/05/24	-	-	-

¹GBP in Million²GBP

Estimates

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E ratio	EV / Sales	EV / EBITDA	Yield (Y)	Capi. ($)
LONZA GROUP AG	47.3x	6.28x	22.11x	+0.85%	45.91B
IQVIA HOLDINGS INC.	30.94x	3.57x	14.84x	-.--%	43.46B
ALNYLAM PHARMACEUTICALS, INC.	-108.03x	14.53x	-248.48x	-.--%	33.6B
CELLTRION, INC.	75.9x	11.57x	39.99x	+0.26%	30.11B
MODERNA, INC.	-7.59x	6.14x	-5.78x	-.--%	26.78B
ICON PUBLIC LIMITED COMPANY	32.41x	3.19x	14.76x	-.--%	24.82B
UNITED THERAPEUTICS CORPORATION	13.78x	4.54x	8.85x	-.--%	15.18B
BIO-TECHNE CORPORATION	60.93x	9.46x	26.99x	+0.44%	11.61B
MEDPACE HOLDINGS, INC.	29.77x	4.65x	22.32x	-.--%	10.67B
Average	19.49x	7.10x	-11.60x	+0.17%	26.9B
Weighted average by Cap.	16.55x	7.24x	-18.95x	+0.21%